Nubeqa 300 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FYEA4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,284
Award facts
- Contract value 100% obligated
- $15,283.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,283.96 for 120 tablets of Nubeqa 300 mg, with an ultimate completion date of August 22, 2025. This firm fixed-price contract, awarded on August 1, 2025, represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to military healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal agencies, particularly supporting the Defense Health Agency and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for Nubeqa—an oncology medication used in prostate cancer treatment—reflects the company's role in supplying specialized pharmaceuticals to support military medical readiness and veteran healthcare requirements through the DLA's medical supply chain network.
Quick answers
Who was awarded contract SPE2DB25FYEA4?
SPE2DB25FYEA4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FYEA4 worth?
The government has obligated $15,284 on SPE2DB25FYEA4.
Is contract SPE2DB25FYEA4 an order under another contract?
Yes. SPE2DB25FYEA4 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYEA4 competed?
The extent of competition for SPE2DB25FYEA4 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award